Clinical Trial Update: Relapse Myeloma; Cyclofosfamide; Bortezomib; Maintenance [Phase 2]

View source ↗

Summary

A Phase 2 maintenance trial for relapsed multiple myeloma using cyclophosphamide and bortezomib has completed. Sponsored by University Medical Center Groningen.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Velcade (bortezomib)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED